Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Gross Profit (2024 - 2025)

Indivior Pharmaceuticals has reported Gross Profit over the past 2 years, most recently at $292.0 million for Q4 2025.

  • Quarterly results put Gross Profit at $292.0 million for Q4 2025, up 16.8% from a year ago — trailing twelve months through Dec 2025 was $993.0 million (up 3.76% YoY), and the annual figure for FY2025 was $994.0 million, up 3.87%.
  • Gross Profit for Q4 2025 was $292.0 million at Indivior Pharmaceuticals, up from $230.0 million in the prior quarter.
  • Over the last five years, Gross Profit for INDV hit a ceiling of $292.0 million in Q4 2025 and a floor of $220.0 million in Q2 2024.